Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

4.8%

1 terminated out of 21 trials

Success Rate

93.3%

+6.8% vs benchmark

Late-Stage Pipeline

29%

6 trials in Phase 3/4

Results Transparency

14%

2 of 14 completed with results

Key Signals

2 with results93% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (5)
P 2 (2)
P 3 (2)
P 4 (4)

Trial Status

Completed14
Unknown4
Terminated1
Withdrawn1
Enrolling By Invitation1

Trial Success Rate

93.3%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT01997242Completed

The Surgery After Stenting (SAS) Registry

NCT06585215Enrolling By Invitation

Standardization of Physician-Modified Stent Grafts for Abdominal Aortic Aneurysms

NCT03119012Phase 4Terminated

P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold

NCT05872074Not ApplicableUnknown

Immediate and Short Term Outcomes for Using Drug Coated Balloons in Treating Coronary Bifurcation Lesions

NCT05556668Completed

Percutaneous Biodegradable Biliary Stents for the Treatment of Benign Biliary Strictures.

NCT03375411Not ApplicableWithdrawnPrimary

First-in-Man Study: Safety and Efficacy of INC-1 Bare Metal Stent in the Novo Coronary Lesions.

NCT01900691Not ApplicableCompleted

Removal of the Evolution® Esophageal Stent - Fully Covered

NCT01124942Not ApplicableCompleted

MGuard Stent in ST-elevation Myocardial Infarction

NCT02811796Completed

Angio-based Fractional Flow Reserve to Predict Adverse Events After Stent Implantation

NCT03989557Phase 4Completed

Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial Aneurysms

NCT04115696Completed

Biodegradable Stent Implantation in Biliary Benign Strictures.

NCT03521700Phase 2Completed

Compare Effects of Intensive Versus Conventional Lipid-lowering Therapy in Patients With Severe Atherosclerotic Renal Artery Stenosis Undergoing Stent Placement

NCT00937573Completed

Xience V at Wake Forest University Baptist Medical Center (WFUBMC)

NCT01962168Completed

Evolution® Biliary Stent System Clinical Study

NCT01056744Phase 4CompletedPrimary

Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everolimus-Eluting Coronary Stents

NCT00769938Phase 4Completed

WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing)

NCT00180479Phase 3CompletedPrimary

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

NCT00691314Not ApplicableCompleted

Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis

NCT01172158UnknownPrimary

SMS Reminder for Forgotten Ureteral Stents

NCT01160900Phase 3Unknown

FIT (Fast Infarction Treatment): Complete Revascularization During Primary Percutaneous Coronary Intervention (PCI) Can be Achieved Safely With an Improved Clinical Outcome During the Indexed Hospitalization.

Scroll to load more

Research Network

Activity Timeline